Basic Memorandum of Understanding to Co-develop the Anti-Fungal Agent PEKIRON Nail lacquer
November 27, 2001
Kyorin Pharmaceutical Co., Ltd. (Head office: Tokyo, President: Ikuo Ogihara) and Maruho Co., Ltd (Head office: Osaka, President: Koichi Takagi) have signed a Basic Memorandum of Understanding to co-develop in Japan the anti-fungal agent PEKIRON® nail lacquer currently under development by Kyorin Pharamceutical.
The Basic Memorandum of Understanding represents a joint meeting of interests, with Kyorin Pharmaceutical seeking faster development of PEKIRON® nail lacquer in Japan and Maruho's desire to build a development pipeline to strengthen its dermatology field.
- Basic Memorandum of Understanding to Co-develop the Anti-Fungal Agent PEKIRON Nail lacquer [ PDF 13.2 KB ]
Adobe Reader software is required to view and print PDF files. The latest version of Adobe Reader can be downloaded by accessing the Adobe Systems Incorporated website.